Harvest Health & Recreation Inc. Reports Third Quarter 2020 Financial Results

- Third quarter revenue was $61.6 million , up 86% from the third quarter 2019 and 11% sequentially

- Third quarter adjusted EBITDA was $10.5 million , compared to $4.1 million in the second quarter of 2020

- 2020 revenue target increased to greater than $225 million , up from $215 -220 million

PHOENIX , Nov. 10, 2020 /PRNewswire/ -- Harvest Health & Recreation Inc. ("Harvest" or the "Company") (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today reported its financial and operating results for the third quarter 2020. All financial information is provided in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results

  • Total revenue in the third quarter was $61.6 million , an increase of 86% from $33.2 million in the third quarter of 2019, and up 11% compared to $55.7 million in the second quarter of 2020.
  • Gross profit excluding biological adjustments in the third quarter was $28.7 million , compared to $11.6 million in the third quarter of 2019, and $23.4 million in the second quarter of 2020.
  • Gross profit margin excluding biological adjustments in the third quarter was 46.6%, compared to 35.0% in the third quarter of 2019, and 42.1% in the second quarter of 2020.
  • Net loss was $2.1 million for the third quarter, compared to a net loss of $39.1 million in the third quarter of 2019 and $18.3 million for the second quarter 2020.
  • Adjusted EBITDA excluding biological adjustments in the third quarter was $10.5 million , compared to ($10.9) million in the third quarter of 2019 and $4.1 million in the second quarter of 2020.

Please see the supplemental information regarding unaudited results and Non-IFRS Financial Measures at the end of this press release.

Third Quarter 2020 Business Highlights

  • During the third quarter of 2020, Harvest opened one new dispensary in Phoenix, Arizona and one new dispensary in Cranberry Township, Pennsylvania .
  • As of September 30, 2020 , Harvest owned, operated, or managed 37 retail locations in seven states, including 15 open dispensaries in Arizona . Harvest owned and operated dispensaries exclude retail locations serviced through Interurban.

Subsequent Events

  • Subsequent to September 30, 2020 , Harvest opened two retail locations in Camp Hill and King of Prussia, Pennsylvania .
  • On October 2, 2020 , Harvest terminated the agreement to sell two California retail assets to Hightimes Holdings for $6 million in preferred stock.
  • On October 28, 2020 , Harvest completed a bought deal financing raising gross proceeds of approximately $32.4 million including the overallotment option. Units sold in the offering were priced at Cd$2.26 per unit and included one subordinate voting share and one-half warrant. Each warrant has an exercise price of Cd$3.05 and duration of 30 months.
  • On October 30, 2020 , Harvest completed the purchase and license transfer of THChocolate, LLC, including cannabis manufacturing licenses in Colorado . The consideration paid was immaterial.
  • On November 2, 2020 , Harvest announced a settlement agreement with Devine Holdings. Under the terms of the agreement, Harvest will acquire three vertical medical cannabis licenses in Arizona exchange for the repayment by Devine Holdings of an outstanding $10.45 million receivable owed to Harvest concurrently with the license acquisition.
  • On November 3, 2020 , Arizona voters approved Prop 207, a ballot initiative to allow recreational cannabis consumption in Arizona .

Outlook
Harvest is increasing its full year 2020 revenue target to greater than $225 million , up from the prior target of $215 -220 million. We remain focused on improving the profitability of our business and we expect our gross margins will continue to trend upwards overall, with some quarterly fluctuations due to mix and market changes. This forecast assumes no meaningful impacts or disruptions to our operations as a result of the COVID-19 pandemic.

Management Commentary
"Our third quarter results demonstrate further progress toward our primary goal of returning to profitability through revenue growth, cost controls, and investments in our core markets of Arizona , Florida , Maryland , and Pennsylvania " said Chief Executive Officer Steve White . "We are focused on preparing for recreational cannabis in Arizona in 2021 and continuing to build on this positive momentum as we execute on our plan."

Conference Call & Webcast
Harvest Health and Recreation Inc. will host a conference call and audio webcast with Chief Executive Officer Steve White and Chief Financial Officer Deborah Keeley , Tuesday November 10, 2020 at 5:00 PM Eastern Time .

Registration for this event is required. Please use this link to register: https://www.directeventreg.com/registration/event/3878799

Following registration, an email confirmation will be sent including dial in details and unique conference call codes. Registration will remain open during the call however we recommend advance registration to access the event.

Third quarter results will be available at:
https://investor.harvesthoc.com/financials/default.aspx

The live conference call webcast and replay will be available at:
https://investor.harvesthoc.com/financials/default.aspx

HARVEST HEALTH & RECREATION INC.  
Interim Unaudited Condensed Consolidated Statements of Financial Position  
September 30, 2020 and December 31, 2019  
( Amounts expressed in thousands of United States dollars)  






September 30,

2020



December 31,

2019


ASSETS










Current assets:










Cash and cash equivalents



$

62,756



$

22,685


Restricted cash




8,000




8,000


Accounts receivable, net




17,385




12,147


Notes receivable, current portion




47,705




51,349


Biological assets




26,359




8,057


Inventory, net




41,173




28,774


Other current assets




5,445




4,788


Total current assets




208,823




135,800


Notes receivable, net of current portion




1,444




34,430


Property, plant and equipment, net




158,838




149,867


Right-of-use asset, net




67,083




56,955


Intangibles assets, net




263,923




159,209


Corporate investments




19,091





Acquisition deposits




528




3,645


Goodwill




115,671




84,596


Assets held for sale




5,948




2,444


Other assets




20,654




8,618


TOTAL ASSETS



$

862,003



$

635,564


LIABILITIES AND STOCKHOLDERS' EQUITY










LIABILITIES










Current liabilities:










Accounts payable



$

6,150



$

6,969


Other current liabilities




29,037




21,944


Contingent consideration, current portion




12,446




13,764


Income tax payable




8,104




5,310


Lease liability, current portion




8,289




2,885


Notes payable, current portion




32,711




8,395


Total current liabilities




96,737




59,267


Notes payable, net of current portion




260,997




202,619


Lease liability, net of current portion




61,862




54,621


Deferred tax liability




56,987




28,587


Contingent consideration, net of current portion




1,108




16,249


Other long-term liabilities




208




179


TOTAL LIABILITIES




477,899




361,522


STOCKHOLDERS' EQUITY










Capital stock




652,713




505,709


Accumulated deficit




(275,764)




(235,348)


Stockholders' equity attributed to Harvest Health & Recreation Inc.




376,949




270,361


Non-controlling interest




7,155




3,681


TOTAL STOCKHOLDERS' EQUITY




384,104




274,042


TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY



$

862,003



$

635,564


HARVEST HEALTH & RECREATION INC.

Interim Unaudited Condensed Consolidated Statements   of Operations  
Three and Six Months Ended September 30, 2020 and 2019  
( Amounts expressed in thousands of United States dollars, except share or per share data )






For the three months ended
September 30,



For the nine months ended
September 30,





2020



2019



2020



2019


Revenue, net of discounts



$

61,643



$

33,151



$

161,547



$

78,987


Cost of goods sold




(32,934)




(21,532)




(91,266)




(52,782)


Gross profit before biological asset adjustments




28,709




11,619




70,281




26,205


Realized fair value amounts included in
inventory sold




(24,769)




(17,644)




(53,996)




(31,119)


Unrealized fair value gain on growth of
biological assets




34,385




17,901




74,258




36,748


Gross profit




38,325




11,876




90,543




31,834


Expenses


















General and administrative




20,736




30,998




65,871




71,148


Sales and marketing




834




2,895




3,355




6,537


Share-based compensation




1,268




7,718




18,348




19,115


Depreciation and amortization




3,551




4,491




10,529




7,584


Total expenses




26,389




46,102




98,103




104,384


Operating income (loss)




11,936




(34,226)




(7,560)




(72,550)


Other (expense) income


















Gain (loss) on sale of assets




(140)




116




760




206


Other (expense) income




(32)




(629)




10,223




(878)


Foreign currency gain (loss)




26




277)




(82)




(501)


Interest expense




(13,224)




(5,512)




(32,574)




(8,726)


Contract asset impairment










(2,420)





Loss before taxes and non-controlling
interest




(1,434)




(39,974)




(31,653)




(82,449)


Income taxes




(206)




464)




(5,132)




(3,571)


Loss from continuing operations before non-
controlling interest




(1,640)




(39,510)




(36,785)




(86,020)


Net loss from discontinued operations, net of
tax




(131)







(1,420)





Net loss before non-controlling interest




(1,771)




(39,510)




(38,205)




(86,020)


Loss (gain) attributed to non-controlling
interest




(370)




415




(2,211)




1,383


Net loss attributed to Harvest Health &
Recreation Inc.



$

(2,141)



$

(39,095)



$

(40,416)



$

(84,637)


Loss per share - basic and diluted



$

(0.01)



$

(0.09)



$

(0.12)



$

(0.30)


Attributable to Harvest Health and
Recreation Inc. Stockholders



$

(0.00)



$

(0.09)



$

(0.11)



$

(0.30)


Attributable to discontinued operations, net
of tax



$



$



$



$


Attributable to non-controlling interest



$

(0.00)



$

0.00



$

(0.01)



$

0.00


Weighted-average shares outstanding - basic
and diluted




367,340,268




288,137,942




345,366,810




285,839,909


Non-IFRS Financial and Performance Measures

The Company provides additional financial metrics that are not prepared in accordance with IFRS. Management uses non-IFRS financial measures, in addition to IFRS financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate the Company's financial performance. This non-IFRS financial measure is Adjusted EBITDA.

Management believes that these non-IFRS financial measures reflect the Company's ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business, as they facilitate comparing financial results across accounting periods and to those of peer companies. Management also believes that these non-IFRS financial measures enable investors to evaluate the Company's operating results and future prospects in the same manner as management. These non-IFRS financial measures may also exclude expenses and gains that may be unusual in nature, infrequent or not reflective of the Company's ongoing operating results.

As there are no standardized methods of calculating these non-IFRS measures, the Company's methods may differ from those used by others, and accordingly, the use of these measures may not be directly comparable to similarly titled measures used by others. Accordingly, these non-IFRS measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.

Reconciliations of Non-IFRS Financial and Performance Measures

The table below reconciles Net Loss to Adjusted EBITDA for the periods indicated.



Three months ended
September 30,



Nine months ended
September 30,




2020



2019



2020



2019


Net loss (IFRS) before non-controlling interest


$

(1,771)



$

(39,510)



$

(38,205)



$

(86,020)


Add (deduct) impact of:

















Net interest and other financing costs (1)



13,167




5,512




32,904




9,248


Income tax



206




(464)




5,132




3,571


Amortization and depreciation (2)



4,250




4,894




13,089




9,099


(Gain) loss on assets



140




(116)




(760)




(206)


Other (expense) income



32




629




(10,223)




878


Foreign currency (gain) loss



(26)




(277)




82




501


Share-based compensation expense



1,268




7,718




18,348




19,115


Contract asset impairment









2,420





Discontinued operations, net of tax



131







1,420





Realized fair value amounts included in inventory sold



24,769




17,644




53,996




31,119


Unrealized fair value gain on growth of biological
assets



(34,385)




(17,901)




(74,258)




(36,748)


Other expansion expenses (pre-open)



2,429




4,616




5,356




7,111


Transaction & other special charges



291




6,346




1,693




14,304


Adjusted EBITDA (non-IFRS)


$

10,501



$

(10,909)



$

10,994



$

(28,028)



(1) Includes $(57), $330, $--- and $520  of interest reported in cost of sales.

(2) Includes $698, $2,560, $403 and $1,515 of depreciation reported in cost of sales.

About Harvest Health & Recreation Inc.

Headquartered in Tempe, Arizona , Harvest Health & Recreation Inc. is a vertically integrated cannabis company and multi-state operator. Since 2011, Harvest has been committed to expanding its retail and wholesale presence throughout the U.S., acquiring, manufacturing, and selling cannabis products for patients and consumers in addition to providing services to retail dispensaries. Through organic license wins, service agreements, and targeted acquisitions, Harvest has assembled an operational footprint spanning multiple states in the U.S. Harvest's mission is to improve lives through the goodness of cannabis. We hope you'll join us on our journey:   https://harvesthoc.com  

Facebook: @HarvestHOC
Instagram: @HarvestHOC
Twitter: @HarvestHOC

Forward-looking Statements

This press release includes information, statements, beliefs and opinions which are forward-looking, and which reflect current estimates, expectations and projections about future events, referred to herein and which constitute "forward-looking statements" or "forward-looking information" within the meaning of Canadian and U.S. securities laws. Statements containing the words "believe", "expect", "intend", "should", "seek", "anticipate", "will", "positioned", "project", "risk", "plan", "may", "estimate" or, in each case, their negative and words of similar meaning are intended to identify forward-looking statements. By their nature, forward-looking statements involve a number of known and unknown risks, uncertainties and assumptions concerning, among other things, the effects of the weather, natural disasters, and health pandemics, including the novel coronavirus (COVID-19), on customer demand, the Company's supply chain as well as its consolidated results of operation, financial position and cash flows, the ability of Harvest to develop Harvest's brand and meet its growth objectives, the ability of Harvest to complete planned acquisitions that are accretive to its revenue, the ability of Harvest to obtain and/or maintain licenses to operate in the jurisdictions in which it operates or in which it expects or plans to operate; changes in general economic, business and political conditions, including changes in the financial markets; and in particular the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws, including those related to taxation; the inability to locate and acquire suitable companies, properties or assets necessary to execute on the Company's business plans; and increasing costs of compliance with extensive government regulation. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. In addition, even if the outcome and financial effects of the plans and events described herein are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in subsequent periods. Although the Company has attempted to identify important risks and factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors and risks that cause actions, events or results not to be as anticipated, estimated or intended. Forward-looking information contained in this press release is based on the Company's current estimates, expectations and projections, which the Company believes are reasonable as of the current date. The Company can give no assurance that these estimates, expectations and projections will prove to have been correct. You should not place undue reliance on forward-looking statements, which are based on the information available as of the date of this press release. Forward-looking statements contained in this press release are made of the date of this press release and, except as required by applicable law, the Company assumes no obligation to update or revise them to reflect new events or circumstances. Historical statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. In this regard, certain financial information contained herein has been extracted from, or based upon, information available in the public domain and/or provided by the Company. In particular historical results should not be taken as a representation that such trends will be replicated in the future. No statement in this press release is intended to be a profit forecast. While the information contained herein is believed to be accurate, the Company, its affiliates, and their respective stockholders, members, partners, directors, managers, officers, employees, agents, advisors, and other representatives each expressly disclaims any and all liability for representations, expressed or implied, contained in or omitted from this press release or any other written or oral communications transmitted to any interested party in the course of its evaluation of the Company. Nothing contained herein is or shall be relied upon as a promise or representation by the Company or their affiliates or any of their respective stockholders, members, partners, directors, managers, officers, employees, agents, advisors, or other representatives as to the past or future performance of the Company. Only those particular representations and warranties made by the Company in a written definitive agreement, when and if one is executed, and subject to such limitations and restrictions as may be specified in such agreement, shall have any legal effect.

To the extent any forward-looking information in this press release constitutes "future-oriented financial information" or "financial outlooks" within the meaning of applicable Canadian securities laws, such information is being provided to demonstrate the anticipated market penetration and the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such future-oriented financial information and financial outlooks. Future-oriented financial information and financial outlooks, as with forward-looking information generally, are, without limitation, based on the assumptions and subject to the risks set out above under the heading "Forward-Looking Information." Please also see risks highlighted under the heading "Risk Factors" in our Canadian filings, and under the heading "Item 1A. Risk Factors" in our recent Form 10 filing with the U.S Securities and Exchange Commission, as well as our subsequent filings in the United States and Canada . Harvest's actual financial position and results of operations may differ materially from management's current expectations and, as a result, Harvest's revenue and expenses may differ materially from the revenue and expenses profiles provided in this press release. Such information is presented for illustrative purposes only and may not be an indication of Harvest's actual financial position or results of operations.

Additional Information

The financial information reported in this news release is based on unaudited management prepared financial statements for the quarter ended September 30, 2020 . Accordingly, such financial information may be subject to change. Financial statements for the period will be released and filed under the Company's profiles on SEDAR at www.SEDAR.com by November 29, 2020 . All financial information contained in this news release is qualified in its entirety with reference to such unaudited financial statements. While Harvest does not expect there to be any material changes, to the extent that the financial information contained in this news release is inconsistent with the information contained in the unaudited financial statements, the financial information contained in this news release shall be deemed to be modified or superseded by Harvest's unaudited financial statements. The making of a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation for purposes of applicable securities laws.

Cision View original content: https://www.prnewswire.com/news-releases/harvest-health--recreation-inc-reports-third-quarter-2020-financial-results-301170240.html

SOURCE Harvest Health & Recreation Inc.

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.

Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will reach AU$3.73 billion in 2024 and grow at an annual rate of 3.22 percent, culminating in market volume worth AU$4.53 billion by 2029.

However, Australia’s cannabis industry is still young. Despite there being a strong case for a regulated market, which was outlined in a July 2024 report by the Penington Institute, recreational use is not legal and medical access remains limited and regulated.

Keep reading...Show less
Cannabis leaf on road marked with "2025," with sunlight in the background.

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025

Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve.

Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among younger users, and cannabis companies are adapting their offerings to meet shifting demand.

Meanwhile, regulatory uncertainty, particularly surrounding the future of the US Farm Bill and state-level restrictions on hemp-derived cannabinoids, continues to challenge the market.

Despite these headwinds, production data and long-term growth forecasts suggest the cannabis industry remains on a promising — albeit turbulent — path. Read on for more on key trends to watch in 2025.

Consumption methods evolving post-legalization

Shifts in consumer behavior are reshaping markets across the board, and the cannabis industry is no exception.

While smoking remains the dominant method of cannabis consumption, a recent report from the Centers for Disease Control and Prevention highlights the growing popularity of edibles, vaping and dabbing.

The report notes that vaping and dabbing are particularly pronounced among younger adults.

A separate study published by the American Medical Association and funded in part by the Canadian Institutes of Health Research also points to how product preferences have changed among Canadian users since legalization in 2018.


The study indicates that while the use of flower, cannabis concentrates, oil, tinctures and topicals has decreased during that time, the use of vape cartridges, edibles and beverages has increased.

Edibles and beverages were legalized in Canada in late 2019, and Truss Beverage was one of the first players to introduce cannabis-infused drinks. Truss was a joint venture formed by Molson Coors Canada (TSX:TPX.A,TSX:TPX.B) and HEXO, a cannabis company that has since been acquired by Tilray Brands (TSX:TLRY,NASDAQ:TLRY).

In early 2020, Tilray launched a lineup of confectionery, wellness products and beverages through its subsidiary, High Park; Canopy Growth (TSX:WEED,NASDAQ:CGC) made a similar move. These companies gradually brought their products to the US as more states legalized cannabis for medical and/or recreational use.

Today, established cannabis brands typically offer edibles and beverages alongside their other products. Organigram Global (TSX:OGI,NASDAQ:OGI) is one of the newest US entrants, with its April acquisition of Collective Project providing immediate access to the US hemp-derived THC beverage market.

Growing awareness of health and wellness, potentially amplified by the pandemic-led adoption of health trackers, appears to be making an impact on the alcoholic beverage market.

A 2023 Gallup poll reveals a two decade decline in alcohol consumption, particularly among younger adults, suggesting a shift towards more health-conscious lifestyles within this demographic.

Craft beer production declined by 4 percent year-on-year in 2024, according to data collected by the Brewers Association. This marked the largest drop in the industry's history, excluding the pandemic. For small, independent craft breweries, 2024 marked the third consecutive year of declining production. A drop in the number of operating small breweries last year provides further evidence of this trend, with 501 closures in 2024 versus 434 openings.

Challenges in the alcohol market extend beyond the brewing industry, with the New York Times recently reporting the closure of a handful of nightclubs facing decreased alcohol sales alongside rising insurance and rent costs.

Meanwhile, cannabis lounges have been popping up across the US for the last several years. As of early 2025, several states had legalized or were in the process of implementing regulations for cannabis consumption lounges.

Hemp market growth despite regulatory uncertainty

The burgeoning hemp industry is another segment of the expanding cannabis market.

The legalization of industrial hemp — defined as cannabis with a THC concentration of 0.3 percent or less — through the 2018 Farm Bill led to initial investment and optimistic projections for CBD wellness products and various industrial applications. The sector’s rapid evolution also brought the rise of hemp-derived intoxicating cannabinoids, creating a market that presented both opportunities and complexities for participants.

However, after an initial boom, a lack of infrastructure and clearly defined regulations for CBD, as well as state-level variations and market oversupply, ultimately contributed to a quick retraction.

2024 was a pivotal year for the US hemp industry, as the hemp-related provisions of the 2018 Farm Bill — originally set to expire in September 2023, but extended to December 31, 2024 — created an urgent need to address critical issues like THC limits and the regulation of novel hemp-derived cannabinoids. A major point of contention was the proposed shift from defining hemp based on Delta-9 THC concentration (0.3 percent or less) to “total THC,” which includes THCA.

This change had the potential to significantly impact farmers and processors, as many hemp varieties that are compliant under the Delta-9 THC rule could exceed the 0.3 percent limit when THCA is included.

Various bills and amendments were proposed in 2024 as part of the Farm Bill discussions, each with different approaches to regulating hemp. Separate regulatory frameworks for industrial hemp and hemp grown for cannabinoids were suggested, and many states took their own action, leading to a patchwork of regulations and even outright bans.

Despite challenges, data from the US Department of Agriculture suggests signs of recovery.

The department's annual National Hemp Report from 2024 points to an 18 percent increase in industrial hemp production value between 2022 and 2023, with output growth seen in specific sectors like floral (18 percent), fiber (133 percent) and seed hemp (414 percent). The 2025 report from the Department of Agriculture indicates further expansion, with notable increases observed in both acreage (up 64 percent from 2023) and value (46 percent).

The 2024 Farm Bill ultimately did not pass, and right now the hemp industry is operating under a temporary extension of the 2018 Farm Bill under the American Relief Act of 2025, signed into law on December 21, 2024.

The 2018 Farm Bill is now set to expire on September 30, 2025.

While analysts for Markets and Markets project that the North American hemp industry will grow at a CAGR of 22.4 percent and ultimately reach a valuation of US$30.24 billion by 2029, the future of the industry will be heavily influenced by the outcome of the ongoing Farm Bill discussions.

US cannabis legalization remains stalled

Although there is clear demand for cannabis products, the now-defunct rescheduling process in the US is likely to continue casting a shadow of uncertainty over the industry's long-term trajectory.

Legal and procedural delays, including allegations of improper conduct and bias within the US Drug Enforcement Administration (DEA), led to hearing cancellations, and the new administration of US President Donald Trump has brought leadership changes to key agencies like the DEA and the Department of Justice.

Terry Cole, who Trump nominated to be DEA administrator on February 11, has a history of opposing cannabis legalization in the country. Similarly, Pam Bondi, Trump’s pick to lead the justice department, staunchly opposed a movement to legalize medical cannabis during her tenure as Florida’s attorney general.

While there have been bipartisan efforts in Congress to end federal cannabis prohibition and establish regulations for eventual legalization, the DEA’s actions and statements indicate a potential stall or reversal of progress.

In addition to that, new research is adding complexity to the debate.

A study published in the American Journal of Psychiatry this past March highlights an association between the use of high-potency cannabis strains and increased risks of psychosis, a factor that may not have been fully considered by the Department of Health and Human Services. As stronger cannabis strains become more widely available, a reassessment of their potential health risks may be required.

Investor takeaway

While the cannabis industry holds promise for growth and innovation, investors must remain acutely aware of the regulatory uncertainties and market volatility that will undoubtedly shape its trajectory in the years to come.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

Person touching a cannabis plant; Australia map in flag colours.

ASX Cannabis Stocks: 10 Biggest Companies

While Australia has yet to legalise all forms of cannabis, the country is a growing medical cannabis and hemp market, with many companies manufacturing, researching and exporting the plant-based product.

Medical cannabis was federally legalised in 2016, and the export of cannabis from Australia was legalised in 2018. As for recreational use, the only state to legalise recreational use and possession so far is the Australian Capital Territory, which did so in 2020, but it did not establish a regulated recreational cannabis market.

The country's medical cannabis market has been steadily expanding in size and scope. A Penington Institute report shows that Australians spent approximately AU$400 million on medicinal cannabis in the first half of 2024, 72 percent higher than the AU$234 million they spent over the entirety of 2022.

Keep reading...Show less
Cannabis leaves, gavel.

Cannabis Round-Up: Rescheduling Faces New Roadblocks, SAFER Banking Act Gets Another Look

February 2025 was characterized by an evolving legislative landscape and important financial updates from major players.

These developments underscore the complex and dynamic nature of the sector as it continues to navigate legal, financial, and regulatory challenges while experiencing ongoing growth and evolution.

Discussions around cannabis rescheduling, changes in federal agency leadership, state-level legalization efforts, and financial reports from key companies all contributed to a month of notable activity in the cannabis space.

Keep reading...Show less

Trulieve Announces Launch of Onward: A Premium THC Beverage

Available now online and coming soon to select Total Wine locations in Florida

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the launch of Onward, a premium, non-alcoholic THC beverage offering a modern alternative for social occasions. These Farm Bill compliant beverages are available now online and coming soon to select Total Wine locations in Florida .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") will hold its 2024 fourth-quarter and full-year earnings conference call on Thursday, February 27, 2025 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations . To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on the Company's website.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×